Closing Thought

Nov 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
The need for collaboration between the various disciplines and stakeholders is becoming crucial.
Oct 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
A purely empirical approach to drug development may allow for evaluation of the overt factors that impact the balance of benefit and risk, but it will never uncover all potential scenarios for which companies are now being held accountable.
Sep 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
Finding new ways to design and conduct clinical trials in order to prevent Phase III failures.
Aug 01, 2008
Applied Clinical Trials
REMS are new only in name. The basic concept has long been central to drug regulation.
Jul 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
The impact of proactive subject recruitment planning.
Jun 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
Chris Bode, PhD, vice president of corporate development for Absorption Systems, explains the impact of in vitro models relative to the Critical Path Initiative.
May 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
Norbert Clemens, MD, head of clinical development for CRS Clinical Research Services, explains that EDC is more than just technology; it is indeed the new way of thinking about clinical research.
Apr 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
Dr. Steve Dodsworth, director of molecular genetic services for Tepnel Research Products & Services, assesses that with molecular insight comes the opportunity to counter disease development and progression.
Mar 01, 2008
Applied Clinical Trials
Carl Anderson, senior consultant for Biologics Consulting Group, addresses the frequent overuse of Notes to File and concludes that documenting a mistake means absolutely nothing during an FDA inspection.
Feb 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
Dan McDonald, vice president of business development for Excel Life Sciences, assesses the role of Site Management Organizations (SMOs) in India and discusses their contributions, which include GCP training and assistance for investigators.
native1_300x100
lorem ipsum